Latest Earnings Results: Q2 '26
Estimated EPS
-$0.02
Reported EPS
-$0.07
Surprise
-250%
Estimated Rev
$24.88M
Reported Rev
$23.03M
Surprise
-7.41%
Xtant Medical Holdings, Inc. reported total revenue of $23.0 million for the quarter ended June 30, 2026, compared to $35.4 million in the prior year period, reflecting a 35% decrease.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | -$0.03 | -- | -- | N/A |
Q2 '26 | -$0.02 | -$0.07 | -250.00% | MISSED |
Q1 '26 | -$0.01 | -$0.02 | -33.33% | MISSED |
Q4 '25 | -$0.00 | $0.00 | 100.00% | BEAT |
Q3 '25 | -$0.01 | $0.01 | 290.48% | BEAT |